Examination of Cardiovascular Function/ Cardio Respiratory Interaction on Spontaneous Breathing Trials in Patients in the Prolonged Weaning

NCT ID: NCT02569385

Last Updated: 2015-10-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-08-31

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study is to determine the cardiovascular function/ cardio respiratory interaction on spontaneous breathing trials in patients with prolonged weaning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

spontaneous breathing trials

spontaneous breathing trials in patients with prolonged weaning

Spontaneous breathing trial

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spontaneous breathing trial

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* legal Age (≥18 years)
* written informed consent Prior to study participation
* patient in prolonged weaning with NYHA I-II and an actual positive Ventilator Screening test:

1. PaO2 ≥ 60 mmHg at FiO2 ≤ 0.4
2. PEEP ≤ 8 cmH2O
3. Glasgow Coma Scale \> 13
4. Temp. \< 38°C
5. Hb \> 80-100 g/L
6. less requirement on catecholamines (\<0.1µg/kg/min)
* and on these patients are already performed a spontaneous breathing trial with following result:

1. abortion this spontaneous breathing trial \< 30min, but possible \> 10min
2. reason for an abortion was NOT hypercapnia

Exclusion Criteria

* weaning patients are assigned on Group 1-2
* patient with heart failure (NYHA III-IV) and/ or other cardiac comorbidity
* acute NSTEMI (non-ST-segment elevation myocardial infarction)
* pregnancy and breast-feeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

RWTH Aachen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Dreher, MD

Role: PRINCIPAL_INVESTIGATOR

Uniklinik RWTH Aachen, Med. Klinik I

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital RWTH Aachen, Department of Medical Clinic I

Aachen, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michael Dreher, MD

Role: CONTACT

+49 241 80 88763

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CTC-A 15-034

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.